Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/HUMA/Revenue

Humacyte, Inc. (HUMA) Revenue 2024–2025

Humacyte, Inc. (HUMA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.

$2.0MFY2025 · since FY2024: $0 → $2.0M
2425
Fiscal yearValueYoY
FY2025$2.0M—
FY2024$0—

Source: SEC XBRL filings · For reference only · Not investment advice

More HUMA financial trends

HUMA Net incomeHUMA Net marginHUMA Gross profitHUMA Gross marginHUMA Operating incomeHUMA Operating marginHUMA Operating cash flowHUMA Free cash flowHUMA Capital expendituresHUMA Return on equityHUMA Stock buybacksHUMA Dividends paidHUMA Total assetsHUMA Total liabilitiesHUMA Shareholders’ equityHUMA overview →